HUP9800260A1 - Eljárás rekombináns adenovírus előállítására és génterápiai alkalmazása - Google Patents

Eljárás rekombináns adenovírus előállítására és génterápiai alkalmazása

Info

Publication number
HUP9800260A1
HUP9800260A1 HU9800260A HUP9800260A HUP9800260A1 HU P9800260 A1 HUP9800260 A1 HU P9800260A1 HU 9800260 A HU9800260 A HU 9800260A HU P9800260 A HUP9800260 A HU P9800260A HU P9800260 A1 HUP9800260 A1 HU P9800260A1
Authority
HU
Hungary
Prior art keywords
preparing
recombinant adenovirus
adenovirus genome
adenoviruses
production
Prior art date
Application number
HU9800260A
Other languages
English (en)
Inventor
Joël Crouzet
Laurent Naudin
Cécile Orsini
Emmanuelle Vigne
Patrice Yeh
Original Assignee
Rhone-Poulenc Rorer S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9476085&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP9800260(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone-Poulenc Rorer S.A. filed Critical Rhone-Poulenc Rorer S.A.
Publication of HUP9800260A1 publication Critical patent/HUP9800260A1/hu
Publication of HUP9800260A3 publication Critical patent/HUP9800260A3/hu
Publication of HU222808B1 publication Critical patent/HU222808B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

A találmány tárgya egy új eljárás rekőmbináns adenővírűselőállítására, és az adenővírűsők alkalmazása a génterápiában. Atalálmány az adenővírűsők előállítására fehasznált plazmidőkra isvőnatkőzik.ŕ
HU9800260A 1995-02-13 1996-02-09 Eljárás rekombináns adenovírusok előállítására, erre szolgáló prokariota plazmidok és az adenovírusokat tartalmazó gyógyszerkészítmények HU222808B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9501632A FR2730504B1 (fr) 1995-02-13 1995-02-13 Procede de preparation de genomes d'adenovirus recombinants
PCT/FR1996/000215 WO1996025506A1 (fr) 1995-02-13 1996-02-09 Procede de preparation de genome d'adenovirus recombinants

Publications (3)

Publication Number Publication Date
HUP9800260A1 true HUP9800260A1 (hu) 1998-05-28
HUP9800260A3 HUP9800260A3 (en) 2000-12-28
HU222808B1 HU222808B1 (hu) 2003-10-28

Family

ID=9476085

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800260A HU222808B1 (hu) 1995-02-13 1996-02-09 Eljárás rekombináns adenovírusok előállítására, erre szolgáló prokariota plazmidok és az adenovírusokat tartalmazó gyógyszerkészítmények

Country Status (19)

Country Link
US (1) US6261807B1 (hu)
EP (1) EP0809704B1 (hu)
JP (1) JP3842818B2 (hu)
KR (1) KR100575521B1 (hu)
AT (1) ATE405662T1 (hu)
AU (1) AU716777B2 (hu)
BR (1) BRPI9607583B8 (hu)
CA (1) CA2210956C (hu)
CZ (1) CZ294338B6 (hu)
DE (1) DE69637648D1 (hu)
FI (1) FI120046B (hu)
FR (1) FR2730504B1 (hu)
HU (1) HU222808B1 (hu)
IL (1) IL117115A (hu)
MX (1) MX9705937A (hu)
NO (1) NO327980B1 (hu)
SK (1) SK286965B6 (hu)
WO (1) WO1996025506A1 (hu)
ZA (1) ZA961153B (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020136708A1 (en) * 1993-06-24 2002-09-26 Graham Frank L. System for production of helper dependent adenovirus vectors based on use of endonucleases
DE19620687A1 (de) * 1996-05-22 1997-11-27 Centeon Pharma Gmbh Neuer adenoviraler Vektor für den Transfer humaner Gene in vivo
AU8067698A (en) * 1997-06-09 1998-12-30 Genvec, Inc. Chimeric vectors comprising a phage packaging site and a portion derived from a genome of a eukaryotic virus
DE69831417T2 (de) 1997-09-23 2006-06-22 Genvec, Inc. Duale selektionkassette und sie enthaltende plasmide
JP2002528056A (ja) * 1998-08-28 2002-09-03 デューク・ユニバーシティー ＩＶａ２、１００Ｋ及び／又は末端前タンパク質配列における欠失型アデノウイルス
AU769735B2 (en) * 1999-02-18 2004-02-05 Advec, Inc. A system for production of helper dependent adenovirus vectors based on use of endonucleases
FR2794771B1 (fr) 1999-06-11 2001-08-10 Aventis Pharma Sa Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
FR2799472B1 (fr) * 1999-10-07 2004-07-16 Aventis Pharma Sa Preparation d'adenovirus recombinants et de banques adenovirales
AU2001234980A1 (en) * 2000-02-09 2001-08-20 Genvec, Inc. Methods of preparing and using a viral vector library
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US6573092B1 (en) 2000-10-10 2003-06-03 Genvec, Inc. Method of preparing a eukaryotic viral vector
AUPR518501A0 (en) 2001-05-22 2001-06-14 Unisearch Limited Yin yang-1
JP2005517394A (ja) 2001-12-12 2005-06-16 エフ エイチ フォールディング アンド カンパニー リミテッド ウイルス保存のための組成物
ATE469984T1 (de) 2003-12-01 2010-06-15 Life Technologies Corp Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
KR20130114758A (ko) 2005-05-27 2013-10-17 오스페달레 산 라파엘 에스.알.엘. Ｍｉ-ｒｎａ를 포함하는 유전자 벡터
KR101445903B1 (ko) 2007-05-02 2014-09-29 메리얼 리미티드 향상된 발현 및 안정성을 갖는 ｄｎａ 플라스미드
US20110269119A1 (en) * 2009-10-30 2011-11-03 Synthetic Genomics, Inc. Encoding text into nucleic acid sequences
PT3021859T (pt) * 2013-10-25 2018-03-09 Psioxus Therapeutics Ltd Adenovírus oncolíticos munidos de genes heterólogos
US10076562B2 (en) 2016-04-19 2018-09-18 The Board Of Regents Of The University Of Texas System Methods for treating plague
AR109540A1 (es) 2016-09-20 2018-12-19 Boehringer Ingelheim Vetmedica Gmbh Moléculas promotoras para expresar antígenos virales
EP3515480A1 (en) 2016-09-20 2019-07-31 Boehringer Ingelheim Vetmedica GmbH New swine influenza vaccine
CN109715204B (zh) 2016-09-20 2023-08-22 勃林格殷格翰动物保健有限公司 新的ehv插入位点orf70
TW201823467A (zh) 2016-09-20 2018-07-01 德商百靈佳殷格翰維美迪加股份有限公司 犬腺病毒載體

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3532566B2 (ja) * 1993-06-24 2004-05-31 エル． グラハム，フランク 遺伝子治療のためのアデノウイルスベクター
CA2144040A1 (fr) * 1993-07-13 1995-01-26 Michel Perricaudet Vecteurs adenoviraux defectifs et utilisation en therapie genique
WO1995003400A1 (en) * 1993-07-23 1995-02-02 Johns Hopkins University School Of Medicine Recombinationally targeted cloning in yeast artificial chromosomes
FR2726285B1 (fr) * 1994-10-28 1996-11-29 Centre Nat Rech Scient Adenovirus depourvus de particules contaminantes viables, preparation et utilisation
DE69534166T2 (de) * 1994-10-28 2006-03-09 Trustees Of The University Of Pennsylvania Rekombinanter adenovirus und methoden zu dessen verwendung
FR2727689A1 (fr) * 1994-12-01 1996-06-07 Transgene Sa Nouveau procede de preparation d'un vecteur viral

Also Published As

Publication number Publication date
HU222808B1 (hu) 2003-10-28
KR100575521B1 (ko) 2006-10-24
CA2210956C (fr) 2010-06-08
MX9705937A (es) 1997-10-31
IL117115A (en) 2005-06-19
CA2210956A1 (fr) 1996-08-22
DE69637648D1 (de) 2008-10-02
FR2730504B1 (fr) 1997-03-28
NO973663D0 (no) 1997-08-08
FR2730504A1 (fr) 1996-08-14
EP0809704A1 (fr) 1997-12-03
FI973309A0 (fi) 1997-08-12
IL117115A0 (en) 1996-06-18
FI973309A (fi) 1997-08-12
EP0809704B1 (fr) 2008-08-20
NO973663L (no) 1997-08-08
SK110097A3 (en) 1998-06-03
CZ294338B6 (cs) 2004-12-15
AU4723596A (en) 1996-09-04
SK286965B6 (sk) 2009-08-06
WO1996025506A1 (fr) 1996-08-22
BR9607583A (pt) 1998-07-07
US6261807B1 (en) 2001-07-17
NO327980B1 (no) 2009-11-02
ATE405662T1 (de) 2008-09-15
JPH11500007A (ja) 1999-01-06
HUP9800260A3 (en) 2000-12-28
BRPI9607583B8 (pt) 2016-11-08
KR19980702139A (ko) 1998-07-15
CZ255497A3 (en) 1997-11-12
JP3842818B2 (ja) 2006-11-08
ZA961153B (en) 1996-08-23
BR9607583B1 (pt) 2009-12-01
FI120046B (fi) 2009-06-15
AU716777B2 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
HUP9800260A1 (hu) Eljárás rekombináns adenovírus előállítására és génterápiai alkalmazása
AU641568B2 (en) Polypeptide,DNA fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
AU7264694A (en) Defective adenovirus vectors and use thereof in gene therapy
HUP9802217A2 (hu) Rekombináns MVA-vírus és alkalmazása
WO1997012986A3 (en) Non-group c adenoviral vectors
DE69331484D1 (de) N-Acetylglucosaminyl-Transferase, dafür kodierendes Gen, entsprechende Vektoren und transformierte Wirte und Herstellungsverfahren dafür
HUP9702377A2 (hu) Önfelerősítő, gyógyszeres úton szabályozható expressziós rendszerek
CY1106216T1 (el) 5´ ESTs ΓΙΑ ΜΗ ΙΣΤΟ-ΕΙΔΙΚΕΣ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ
ATE440141T1 (de) Virales material und mit multipler sklerose assoziierte nukleotidfragmente mit diagnostischen,prophylaktischen und therapeutischen verwendungen
CA2011878A1 (en) Immunogenic regions on the e7 protein of human papillomavirus type 16
HUP0004795A2 (hu) Univerzálisan alkalmazható vérplazma
HUP9800377A1 (hu) Új növekedési faktor és ezt kódoló génszekvencia
FI951403A0 (fi) Polypeptidit, jotka liittyvät streptogramiinien biosynteesiin, näitä polypeptidejä koodittavat nukleotidisekvenssit, ja niiden käyttö
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
HUP9903432A2 (hu) 19-Norkolán szteroidok mint a humán hipotalamusz működésében változást okozó neurokémiai iniciátorok
HUP9901346A2 (hu) Deltap62 polipeptid és variánsai, ezeket kódoló nukleinsav-szekvenciák és felhasználásuk
HUP9903779A2 (hu) Eljárás amiotrófiás lateroszklerózis kezelésére
AU4037299A (en) Genetically-modified fibroblasts and the use thereof
ZA902436B (en) Purification of c.pseudotuberculosis toxin,and cloning and expression of toxin gene
AU6983796A (en) Arc furnace in particular d.c. arc furnace, and process for preventing overheating of the furnace wall
AU5545896A (en) H. Influenzae HxuB and HxuC genes, proteins and methods of use
HUP0004739A1 (hu) Presenilinekkel kölcsönhatásra képes fehérjéket kódoló nukleinsavak
HUP9902298A2 (hu) Tirozin-hidroxiláz génből származó expressziós rendszer
NO964894D0 (no) Rekombinante viruser, deres fremstilling samt anvendelse av genterapi
WO1994018326A3 (en) Regulatory gene for clavulanic acid biosynthesis

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20030918

GB9A Succession in title

Owner name: AVENTIS PHARMA S.A., FR

Free format text: FORMER OWNER(S): RHONE-POULENC RORER S.A., FR; CENTELION, FR; GENCELL S.A., FR